Lazar David E. → OPGEN INC

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

5 filings by this filer

4 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other 13D/G Filings on OPGEN INC

Filed	Form	Filer	Stake	Shares
2020-05-11	SC	Curetis N.V. in Liquidation	—	—	view →
2020-04-22	SC	Curetis N.V. in Liquidation	—	—	view →
2019-02-14	SC	Merck Global Health Innovation Fund, LLC	—	—	view →
2018-02-08	SC	Merck Global Health Innovation Fund, LLC	—	—	view →

Other Filings by Lazar David E.

Filed	Form	Issuer	Stake	Shares
2026-04-28	SCHEDULE 13D	MAINZ BIOMED N.V. QUCY	97.40%	477,000,000	view →
2026-01-29	SCHEDULE	NovaBay Pharmaceuticals, Inc. SDEV	4.99%	6,388,000	view →
2025-03-10	SCHEDULE	FiEE, Inc. FIEE	35.10%	2,802,254	view →
2022-07-11	SC	EQUUS TOTAL RETURN, INC. EQS	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →